Bifidobacterium lactis Probio-M8 Adjuvant Treatment Confers Added Benefits to Patients with Coronary Artery Disease via Target Modulation of the Gut-Heart/-Brain Axes

Baoqing Sun(First Affiliated Hospital of Guangzhou Medical University), Heping Zhang(Inner Mongolia Agricultural University), Lai‐Yu Kwok(Inner Mongolia Agricultural University), Shukun Zhang(Shandong University), Teng Ma(Fudan University), Shuai Guo(Inner Mongolia Agricultural University), Zhihong Sun(Inner Mongolia Agricultural University), Ni Yang(Inner Mongolia Agricultural University), Yalin Li(Inner Mongolia Agricultural University), Xin‐Fu Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Bohai Li(Inner Mongolia Agricultural University)
mSystems
March 28, 2022
10.1128/msystems.00100-22
Cited by 93

Related Papers

Expanding the biotechnology potential of lactobacilli through comparative genomics of 213 strains and associated genera
|Nature Communications|2015|537
Targeting gut microbiota and metabolism as the major probiotic mechanism - An evidence-based review
|Trends in Food Science & Technology|2023|286
Whole-genome sequencing of six dog breeds from continuous altitudes reveals adaptation to high-altitude hypoxia
|Genome Research|2014|227
Probiotic consumption relieved human stress and anxiety symptoms possibly via modulating the neuroactive potential of the gut microbiota
|Neurobiology of Stress|2021|147
The meconium microbiota shares more features with the amniotic fluid microbiota than the maternal fecal and vaginal microbiota
|Gut Microbes|2020|142